바로가기
메인메뉴로 바로가기
콘텐츠 바로가기
하단메뉴로 바로가기
패밀리사이트 바로가기


진료과

  • 연세암병원-종양내과, 부인암센터, 유방암센터

전문진료분야

  • <종양내과> 유방암, 부인암, 항암약물치료, 신약치료

교육 및 임상 경력

  • 2005.03-2011.02    세브란스병원  인턴,  레지던트  수료   
  • 2011.03-2012.11    세브란스병원  종양내과  임상강사
  • 2012.12-2014.01    삼성  바이오에피스  의학부  부장
  • 2014.03-2018.02      연세암병원  종양내과  임상조교수
  • 2018.03-현        재      연세의대  내과학교실  종양내과  조교수

학술관련경력

  • 대한내과학회 회원
  • 대한암학회 회원
  • 한국임상암학회 회원
  • 대한항암요법연구회 회원

주요 관심분야

학력사항

  • 연세대학교 의과대학 의학과 학사 (2002)
  • 연세대학교 의과대학 의학과 석사 (2011)
  • 연세대학교 의과대학 의학과 박사과정 중 (2014-)

논문

  • CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator. Moon YW, An HJ, Koo JS, Kim GM, Han H, Park S, Kim SI, Park HS, Kim S, Kim SK, Lee SA, Hwang S, Son GW, Sohn J. Oncotarget. 2017 Dec 21;9(2):2622-2630
  • Phase II, multicentre, randomised trial of eribulin plus gemcitabine versus paclitaxel plus gemcitabine as first-line chemotherapy in patients with HER2-negative metastatic breast cancer. Park YH, Im SA, Kim SB, Sohn JH, Lee KS, Chae YS, Lee KH, Kim JH, Im YH, Kim JY, Kim TY, Lee KH, Ahn JH, Kim GM, Park IH, Lee SJ, Han HS, Kim SH, Jung KH; Korean Cancer Study Group (KCSG). Eur J Cancer. 2017 Nov;86:385-393
  • Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients. Park S, Koo JS, Kim GM, Sohn J, Kim SI, Cho YU, Park BW, Park VY, Yoon JH, Moon HJ, Kim MJ, Kim EK. Cancer Res Treat. 2017 Aug 17.
  • Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results. Park HS, Park SJ, Kim JY, Kim S, Ryu J, Sohn J, Park S, Kim GM, Hwang IS, Choi JR, Kim SI. Ann Surg Treat Res. 2017 May;92(5):331-339.
  • Prevalence and prognostic implications of psychological distress in patients with gastric cancer. Kim GM, Kim SJ, Song SK, Kim HR, Kang BD, Noh SH, Chung HC, Kim KR, Rha SY. BMC Cancer. 2017 Apr 20;17(1):283
  • The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control. Rha SY, Sohn J, Kim GM, Kim HR, Lee J. Cancer Nurs. 2017 Apr 17
  • A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors. Kim GM, Reid T, Shin SJ, Rha SY, Ahn JB, Lee SS, Chung HC. Invest New Drugs. 2017 Dec;35(6):773-781.
  • Chemotherapy-induced irreversible alopecia in early breast cancer patients.Kim GM, Kim S, Park HS, Kim JY, Nam S, Park S, Kim SI, Kim D, Sohn J. Breast Cancer Res Treat. 2017 Mar 21
  • Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer. Park HS, Sohn J, Kim SI, Park S, Park HS, Gho SG, Chung HC, Paik S, Kim GM. Breast Cancer Res Treat. 2017 Feb 27
  • Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR. Park HS, Han HJ, Lee S, Kim GM, Park S, Choi YA, Lee JD, Kim GM, Sohn J, Kim SI. Yonsei Med J. 2017 Jan;58(1):19-26
  • Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy. Kim CG, Sohn J, Chon H, Kim JH, Heo SJ, Cho H, Kim IJ, Kim SI, Park S, Park HS, Kim GM J Breast Cancer. 2016 Mar;19
  • Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib. Lim S, Han J, Kim GM, Han KH, Choi HJ. J Gastroenterol Hepatol. 2015 Jun;30(6):1024-31
  • FDG PET/CT in hepatocellular carcinoma: detection of bone metastasis and prediction of prognosis. Seo HJ, Kim GM, Kim JH, Kang WJ, Choi HJ. Nucl Med Commun. 2015 Mar;36(3):226-33
  • Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer. Lim S, Cho BC, Jung JY, Kim GM, Kim SH, Kim HR, Kim HS, Lim SM, Park JS, Lee JH, Kim D, Kim EY, Park MS, Kim YS, Kim SK, Chang J, Kim JH. Lung Cancer. 2013 Jun;80(3):313-8
  • Assessment of efficiency and safety of the comprehensive Chemotherapy Assistance Program for ordering oncology medications. Cho E, Kim HJ, Kim GM, Kum J, Chung HK, Lyu CJ, Ahn JB, Shin SJ. Int J Med Inform. 2013 Jun;82(6):504-13
  • Changing treatment patterns in elderly patients with resectable colon cancer. Kim GM, Ahn JB, Rha SY, Kim HS, Kang B, Kim MW, Choi SY, Roh JK, Chung HC, Kim NK, Shin SJ. Asia Pac J Clin Oncol. 2013 Sep;9(3):265-72.
  • The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma. Kim HS, Kim HR, Kim GM, Kim HS, Koh YW, Kim SH, Choi EC, Hong YK, Sung JH, Kim SM, Kim JH, Cho BC. Cancer Chemother Pharmacol. 2012 Oct;70(4):539-46
  • Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients. Kim GM, Kim YS, Ae Kang Y, Jeong JH, Kim SM, Hong YK, Sung JH, Lim ST, Kim JH, Kim SK, Cho BC. J Thorac Oncol. 2012 Apr;7(4):731-6
  • A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer. Kim GM, Jeung HC, Rha SY, Kim HS, Jung I, Nam BH, Lee KH, Chung HC. Eur J Cancer. 2012 Mar;48(4):518-26.
  • Prevalence and associated factors of psychological distress among Korean cancer patients. Kim SJ, Rha SY, Song SK, Namkoong K, Chung HC, Yoon SH, Kim GM, Kim KR. Gen Hosp Psychiatry. 2011 May-Jun;33(3):246-52.
  • A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy. Kim GM, Jeung HC, Kim D, Kim JH, Yoon SH, Jung ES, Shin SJ. Cancer Res Treat. 2010 Dec;42(4):235-8.
  • Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites. Kim JH, Rha SY, Kim C, Kim GM, Yoon SH, Kim KH, Kim MJ, Ahn JB, Chung HC, Roh JK, Kim HS. Cancer Res Treat. 2010 Dec;42(4):217-24.
  • Novel sunitinib strategy in metastatic renal cell carcinoma on hemodialysis: intermittent dose of sunitinib after hemodialysis. Yoon SH, Kim KH, Choi J, Kim GM, Kim JH, Kim HS, Park YN, Rha SY. Cancer Res Treat. 2010 Sep;42(3):180-4
  • Wernicke's encephalopathy in advanced gastric cancer. Jung ES, Kwon O, Lee SH, Lee KB, Kim JH, Yoon SH, Kim GM, Jeung HC, Rha SY. Cancer Res Treat. 2010 Jun;42(2):77-81.
  • Meropenem 내성 Ochrobactrum anthropi 균혈증 1예
    Infection and Chemotherapy(감염과화학요법) 41/1 :62-64,2009
  • Wernicke’s Encephalopathy in Advanced Gastric Cancer
    Cancer Research and Treatment 42/2 :77-81,2010
  • Novel Sunitinib Strategy in Metastatic Renal Cell Carcinoma on Hemodialysis: Intermittent Dose of Sunitinib after Hemodialysis
    Cancer Research and Treatment 42/3 :180-184,2010
  • Clinicopathologic Features of Metachronous or Synchronous Gastric Cancer Patients with Three or More Primary Sites
    Cancer Research and Treatment 42/4 :217-224,2010
  • A Case of Combined Hepatocellular-Cholangiocarcinoma with Favorable Response to Systemic Chemotherapy
    Cancer Research and Treatment 42/4 :235-238,2010
  • Prevalence and associated factors of psychological distress among Korean cancer patients
    GENERAL HOSPITAL PSYCHIATRY 33/3 :246-252,2011
  • A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer
    EUROPEAN JOURNAL OF CANCER 48/ :518-526,2012
  • Efficacy and toxicity of belotecan for relapsed or refractory small cell lung cancer patients
    JOURNAL OF THORACIC ONCOLOGY 7/4 :731-736,2012
  • The efficacy and toxicity of S-1 and cisplatin as first-line chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma
    CANCER CHEMOTHERAPY AND PHARMACOLOGY 70/4 :539-546,2012
  • Phase II study of camtobell inj. (belotecan) in combination with cisplatin in patients with previously untreated, extensive stage small cell lung cancer
    LUNG CANCER 80/3 :313-318,2013
  • Changing treatment patterns in elderly patients with resectable colon cancer
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY 9/3 :265-272,2013
  • 18F-FDG PET/CT in hepatocellular carcinoma: Detection of bone metastasis and prediction of prognosis
    NUCLEAR MEDICINE COMMUNICATIONS 36/3 :226-233,2015
  • Hepatitis B viral load predicts survival in hepatocellular carcinoma patients treated with sorafenib
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 30/6 :1024-1031,2015
  • Incidence of Febrile Neutropenia in Korean Female Breast Cancer Patients Receiving Preoperative or Postoperative Doxorubicin/Cyclophosphamide Followed by Docetaxel Chemotherapy
    JOURNAL OF BREAST CANCER 19/1 :76-82,2016
  • Detection of Circulating Tumor Cells in Breast Cancer Patients Using Cytokeratin-19 Real-Time RT-PCR
    YONSEI MEDICAL JOURNAL 58/1 :19-26,2017
  • Comparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.
    PLOS ONE 12/4 :e0175048-,2017
  • Prevalence and prognostic implications of psychological distress in patients with gastric cancer
    BMC CANCER 17/1 :283-,2017
  • Chemotherapy-induced irreversible alopecia in early breast cancer patients
    BREAST CANCER RESEARCH AND TREATMENT 163/3 :527-533,2017
  • Effects of hormone receptor status on the durable response of trastuzumab-based therapy in metastatic breast cancer
    BREAST CANCER RESEARCH AND TREATMENT 163/2 :255-262,2017
  • A phase 1, open label, dose escalation study to investigate the safety, tolerability, and pharmacokinetics of MG1102 (apolipoprotein(a) Kringle V) in patients with solid tumors
    INVESTIGATIONAL NEW DRUGS 35/6 :773-781,2017
  • Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results
    ANNALS OF SURGICAL TREATMENT AND RESEARCH 92/5 :331-339,2017
  • CD44/CD24 and aldehyde dehydrogenase 1 in estrogen receptor-positive early breast cancer treated with tamoxifen: CD24 positivity is a poor prognosticator
    ONCOTARGET 9/2 :2,622-2,630,2018
  • The Benefit of Pro Re Nata Antiemetics Provided With Guideline-Consistent Antiemetics in Delayed Nausea Control.
    CANCER NURSING 41/2 :49-57,2018
  • Feasibility of Charcoal Tattooing of Cytology-Proven Metastatic Axillary Lymph Node at Diagnosis and Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients
    CANCER RESEARCH AND TREATMENT 50/3 :801-812,2018
  • Comparative clinicopathological and cytomorphological analyses of peritoneal carcinomatosis associated with metastatic breast carcinoma and primary peritoneal/ovarian carcinoma in patients with a history of breast carcinoma
    VIRCHOWS ARCHIV 473/2 :165-175,2018
  • External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence
    Radiation Oncology Journal 36/2 :139-146,2018
  • A Phase II Study to Evaluate the Safety and Efficacy of Pegteograstim in Korean Breast Cancer Patients Receiving Dose-Dense Doxorubicin/Cyclophosphamide.
    CANCER RESEARCH AND TREATMENT 51/2 :812-818,2019
  • Effect of primary tumor resection on overall survival in patients with stage IV breast cancer.
    BREAST JOURNAL 25/5 :908-915,2019
  • Involved-field radiation therapy for selected cases of recurrent ovarian cancer
    JOURNAL OF GYNECOLOGIC ONCOLOGY 30/5 :1-12,2019

김건민

콘텐츠 처음으로 이동

네크워크 링크안내/사이트 정보